Related Articles Premium RA Capital Preps New Biotech SPAC — With an Eye on China’s Risks Stephen Taub China Is Back in Portfolios — But Only for Investors Who Can Live With the Risk Jonathan Kandell Small Caps Stage Quiet Comeback as AI Trade Shows Cracks Sponsored by CME Group